Nav: Home

From bark to bedside: Study looks at canine cancer genes, human health impact

June 21, 2010

EAST LANSING, Mich. -- Michigan State University veterinarians are taking part in a two-year, $5.3 million project to analyze five cancers in dogs, research that could offer new insight into canine cancer genes and their potential impact on the human form of the disease.

The Canine Hereditary Cancer Consortium -- an alliance of veterinarians, scientists, clinicians, nonprofit institutions, universities and industry members -- will focus on purebred dogs, who offer a window into cancer genetics not available with other species, said Barbara Kitchell, director of MSU's Center for Comparative Oncology. She also is a member of the consortium's executive steering committee.

"Because purebred dogs have been selected to have specific physical and behavioral traits, their background genetics, within breeds, are very similar," Kitchell said. "With that 'background noise' suppressed, cancer genes are made more obvious."

The research partnership, entitled From Bark to Bedside, is led by the Van Andel Research Institute in Grand Rapids and the Translational Genomics Research Institute in Phoenix. Participating research teams are MSU, University of Pennsylvania and Colorado State University, as well as the National Cancer Institute.

As part of the group's research, MSU's Vilma Yuzbasiyan-Gurkan, a professor of microbiology and molecular genetics and small animal clinical sciences, specifically is looking at histiocytic sarcomas, which are malignant, soft-tissue tumors that arise from cells in the immune system.

If the tumor is removed before cancer cells spread, the prognosis is good. Once the cancer spreads, most dogs live just a few weeks. The dogs most often affected by this type of cancer are Bernese mountain dogs.

Yuzbasiyan-Gurkan and her team, which includes Matti Kiupel of pathobiology and diagnostic investigations, will rely on a DNA and tumor tissue repository they set up at MSU in 2006 to analyze the gene makeup of Bernese mountain dogs and search for cancer triggers. The MSU repository was established with grant support from the Berner-Garde Foundation and contributions from the Bernese Mountain Dog Club of America.

"We established the repository in anticipation of genomic technology developing to a point where it would be affordable for use with dogs," she said. "The timing is now right; this partnership brings the technology and computing power that are significant components of this task."

The project also aims to identify critical pathways that can be targeted by drugs, Kitchell said.

"For example, there may be a genetic change in a tumor that turns on a growth-promoting signal," she said. "We may discover from the arsenal of drugs and chemicals available to us that we can turn off that gene, allowing us to custom-tailor therapies."

There also are potential human benefits in the project, especially where a type of cancer is common in a particular breed of dog but uncommon in people. Because such large numbers are needed to get reliable findings, advances in human treatment are limited by the small number of people affected.

"With purebred dogs, you not only have a larger population with a particular cancer, but, because of these dogs' reduced genetic complexity, there is a better chance of identifying the responsible gene," Yuzbasiyan-Gurkan said. "It's a win-win situation for the dogs and people."

The other canine cancers being analyzed are non-Hodgkin's lymphoma, oral melanoma, osteosarcoma and hemangiosarcoma. The project is funded by a $4.3 million grant from the National Cancer Institute and $500,000 donations from both Pet Smart and Hill's Pet Nutrition.
-end-
For information on how to participate in the MSU part of the study, contact Yuzbasiyan-Gurkan at (517) 884-5351, yuzbasiyan@cvm.msu.edu or berners@cvm.msu.edu. For information on how to participate in other parts of the study, call (616) 234-5569 or e-mail CHCC@vai.org.

Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.

Michigan State University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...